US Patent Issued to INTRA-CELLULAR THERAPIES on April 8 for "Transmucosal methods for treating psychiatric and neurological conditions" (New Jersey, California Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,686, issued on April 8, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).

"Transmucosal methods for treating psychiatric and neurological conditions" was invented by Peng Li (New Milford, N.J.), Wei Yao (New Milford, N.J.) and Robert Davis (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides new transmucosal and subcutaneous pharmaceutical compositions comprising 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or 1-(4-fluoro-phenyl)-4-((6bR,10aS)-2,2-d2-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrol...